CLINICAL_TRIALS
trial_result
· 2024-07-25
Clinical Trial Update: A Safety Study of Mirikizumab (LY3074828) [Phase 1]
Summary
Phase 1 safety study of mirikizumab (LY3074828) in psoriasis completed; results posted in 2024. The study assessed safety and tolerability in adults with psoria…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Psoriasis | Phase 1 | Status: COMPLETED | Results posted: 2024-07-25